—
SAN ANTONIO, TEXAS / Bio-Solutions Corp (BISU.OTC) has appointed Thomas E. Metzger, PhD as President of the company. "Thomas has been very strategic in his role as COO and as a Board member for us", states William Gallagher, Chairman and CEO "Thomas will serve a duel role as President and COO for our continued growth".
Bio Solutions and Type 2 Defense will continue the health and wellness commitment "Balancing your body’s digestive, circulatory, and immune systems, Type 2 Defense™ is a powder blend of natural ingredients that has been developed to help support healthy blood glucose levels in health-conscious individuals and those diagnosed with Type II Diabetes" a point Thomas E. Metzger, PhD wanted to make clear.
The team William has assembled are top in their respective areas, and will continue to grow as their company grows.
Thomas brings a very impressive background with Executive positions and as a CEO of companies such as South Seas, Wolfgang Puck, Sizzler USA, Kenny Rogers Roasters, Wrapsters and others. He has vast experience in nutrition, hospitality and development management and business management, and currently holds seats on seven (7) Boards of Directors.
"We are poised to take the next steps forward in growth and distribution... Let's GROW!" Metzger stated.
The company also announced on 02/25/2014 a 1-10 Reverse Split of Bio-Solutions Corp (BISU) shares. This corporate action will take effect at the open of business 2/26/2014. The new symbol will be BISUD. The D will be removed in 20 business days.
About Bio-Solutions
Bio-Solutions Corp. markets new and very effective organic products; our lead product is Type2 Defense™. Type2Defense™ a Diabetic Supplement Drink. Type2Defense™ is a new dietary supplement that has been developed to help support healthy blood glucose levels in health-conscious individuals and those diagnosed with Type 2 Diabetes, when substituted over many popular sugar and/or carbohydrate-laden alternatives. The Product's goal is to provide a safe and natural supplement that will assist in the stabilization of healthy glucose levels along with providing strong antioxidants and low carbohydrates. For more information about Type 2 Defense, visit our website http://www.type2defense.com/
"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: This release includes forward-looking statements intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. All statements which address actual results could differ materially from those expressed or implied in forward-looking statements. These statements are made on the basis of management's views and assumptions. As a result, there can be no assurance that management's expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as management "believes", "expects", "anticipates", "foresees", "forecasts", "estimates" or other words or phrases of similar import. Similarly, statements in this release that describe the Company's business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. Management cautions that the ability to attract clients and generate business may be affected by a decline in the Company's financial ratings, the competitive environment, the Company's ability to raise sufficient capital to meet the collateral requirements associated with its current business and to fund the Company's continuing operations and changes in market conditions.
Contact:
Bill Gallagher, President & CEO
Bio-Solutions Corp.
Investor Relations Contact
William Gallagher
+1-210-218-4475
info@biosolutionscorp.com
Source: Bio-Solutions Corp.
Release ID: 34387